TNFSF10 and hepatocellular carcinoma: Regarding HCC, in 2018, Kang and co-workers corroborated the ability of apigenin to enhance TRAIL-induced apoptosis in both the Hep3B and HepG2 cell lines, linking these effects with a reactive oxygen species (ROS)-independent increase in DR5 levels [45].